50 results on '"Walshaw, Martin J"'
Search Results
2. The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)
3. Cystic fibrosis: Diagnosis and management – NICE guideline 78
4. Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry
5. Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes
6. Dynamic chest radiography: a state-of-the-art review.
7. Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?
8. A Subtype of a Pseudomonas aeruginosa Cystic Fibrosis Epidemic Strain Exhibits Enhanced Virulence in a Murine Model of Acute Respiratory Infection
9. Divergent, Coexisting Pseudomonas aeruginosa Lineages in Chronic Cystic Fibrosis Lung Infections
10. Developing an ecological approach to physical activity promotion in adults with Cystic fibrosis.
11. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance
12. PCR-Based Detection of a Cystic Fibrosis Epidemic Strain of Pseudomonas Aeruginosa
13. Are early life factors considered when managing respiratory disease? A British Thoracic Society survey of current practice
14. Pseudomonas aeruginosa Population Diversity and Turnover in Cystic Fibrosis Chronic Infections
15. Empyema due to a highly transmissible Pseudomonas aeruginosa strain in an adult cystic fibrosis patient
16. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations
17. Long-Term Effect of Insulin Treatment in Cystic Fibrosis-Related Diabetes
18. Management of Cystic Fibrosis Related Diabetes: A Survey of UK Cystic Fibrosis Centers
19. Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach
20. Development of a diagnostic test for the Midlands 1 cystic fibrosis epidemic strain of Pseudomonas aeruginosa
21. Use of suppression subtractive hybridization to examine the accessory genome of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa
22. Targeting DNase in cystic fibrosis
23. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain
24. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa
25. Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data.
26. Prescription Of Oxygen Concentrators For Long Term Oxygen Treatment: Reassessment In One District
27. Cystic Fibrosis Related Diabetes
28. Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis
29. Expiratory lung crackles in patients with fibrosing alveolitis
30. Between a Rock and an Airspace: Pneumothorax After Extracorporeal Shock Wave Lithotripsy for Renal Stones in a Patient With Cystic Fibrosis.
31. Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections.
32. Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES)
33. Impact of 18 F-FDG PET scan on the prevalence of benign thoracic lesions at surgical resection.
34. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.
35. Pseudomonas aeruginosa cross-infection in cystic fibrosis.
36. Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study.
37. Dynamic chest radiography in the workup of lung cancer.
38. Use of Dynamic Chest Radiography to Assess Treatment of Pulmonary Exacerbations in Cystic Fibrosis.
39. Characterisation of hemidiaphragm dysfunction using dynamic chest radiography: a pilot study.
40. Transmission, adaptation and geographical spread of the Pseudomonas aeruginosa Liverpool epidemic strain.
41. Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach.
42. Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain.
43. Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.
44. Halting the spread of epidemic pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study.
45. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections.
46. Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study.
47. Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
48. Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infections.
49. Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
50. A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.